Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 25  Show
  1. 1
    "Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration."
    Fathallah-Shaykh H., Wolf S., Wong E., Posner J.B., Furneaux H.M.
    Proc. Natl. Acad. Sci. U.S.A. 88:3451-3454(1991) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Testis.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12928 other entries.

  3. 3
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Eye.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50454 other entries.

  5. 5
    "Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration."
    Sakai K., Mitchell D.J., Tsukamoto T., Steinman L.
    Ann. Neurol. 28:692-698(1990) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 6-454.
    Category: Sequences.
    Tissue: Cerebellum.
    Source: UniProtKB/Swiss-Prot (reviewed).
  6. 6
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 8820 other entries.

  7. 7
    "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
    Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
    Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Tissue: Leukemic T-cell.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 5604 other entries.

  8. 8
    "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
    Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.
    Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 5612 other entries.

  9. 9
    "Toward a comprehensive characterization of a human cancer cell phosphoproteome."
    Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., Mohammed S.
    J. Proteome Res. 12:260-271(2013) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 13490 other entries.

  10. 10
    "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."
    Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., Ye M., Zou H.
    J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Tissue: Liver.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 11670 other entries.

  11. 11
    "The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival."
    Okano H.J., Park W.Y., Corradi J.P., Darnell R.B.
    Genes Dev. 13:2087-2097(1999) [PubMed] [Europe PMC] [Abstract]
    Category: Subcellular Location, Interaction.
    Annotation: Identifies c-Myc interaction with cdr2 by co-IP and co-localization in cytoplasm of cerebellar Purkinje neurons. Sera from 6/6 patients with cdr2 autoantibodies and paraneoplastic cerebellar degeneration block this interaction.Imported.
    Source: GeneRIF:1039.
  12. 12
    "Interaction of a paraneoplastic cerebellar degeneration-associated neuronal protein with the nuclear helix-loop-helix leucine zipper protein MRG X."
    Sakai K., Shirakawa T., Li Y., Kitagawa Y., Hirose G.
    Mol. Cell. Neurosci. 19:477-484(2002) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q01850.

    This publication is mapped to 3 other entries.

  13. 13
    "An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies."
    Sutton I.J., Steele J., Savage C.O., Winer J.B., Young L.S.
    J. Neuroimmunol. 150:98-106(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Sequences.
    Annotation: In patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies IFN-gamma-secreting cell responses towards Cdr2 isoforms are not detected suggesting a limited role for cytotoxic T lymphocyte-mediated tumor immunity in this patient group.Imported.
    Source: GeneRIF:1039.
  14. 14
    "Infection of human B lymphoma cells by Mycoplasma fermentans induces interaction of its elongation factor with the intracytoplasmic domain of Epstein-Barr virus receptor (gp140, EBV/C3dR, CR2, CD21)."
    Balbo M., Barel M., Lottin-Divoux S., Jean D., Frade R.
    FEMS Microbiol. Lett. 249:359-366(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Annotation: Mycoplasma fermentans in infecting human B cells generates a Mycoplasma component that interacts with CD21 which is involved in B cell proliferation.Imported.
    Source: GeneRIF:1039.
  15. 15
    "Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response."
    Balamurugan K., Luu V.D., Kaufmann M.R., Hofmann V.S., Boysen G., Barth S., Bordoli M.R., Stiehl D.P., Moch H., Schraml P., Wenger R.H., Camenisch G.
    Oncogene 28:3274-3285(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Subcellular Location, Expression.
    Annotation: Cdr2 protein strongly accumulates in papillary renal cell carcinoma attenuates the HIF response to tumor hypoxia and may become of diagnostic importance as novel renal tumor marker.Imported.
    Source: GeneRIF:1039.
  16. 16
    "Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo)."
    Totland C., Bredholt G., Haugen M., Haukanes B.I., Vedeler C.A.
    Cancer Immunol. Immunother. 59:231-237(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Subcellular Location.
    Annotation: The association between Yo and CCDC104 antibodies in paraneoplastic neurological syndromes may indicate functional similarities.Imported.
    Source: GeneRIF:1039.

    This publication is cited by 1 other entry.

  17. 17
    "Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score."
    Rose J.E., Behm F.M., Drgon T., Johnson C., Uhl G.R.
    Mol. Med. 16:247-253(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)Imported.
    Source: GeneRIF:1039.

    This publication is mapped to 11756 other entries.

  18. 18
    Category: Sequences.
    Annotation: The results suggest that Yo antibodies are not only related to the expression of CDR2 alone but also to immune dysregulation.Imported.
    Source: GeneRIF:1039.
  19. 19
    Category: Interaction.
    Source: IntAct:Q01850.

    This publication is mapped to 2553 other entries.

  20. 20
    "Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration."
    Rojas-Marcos I., Picard G., Chinchon D., Gelpi E., Psimaras D., Giometto B., Delattre J.Y., Honnorat J., Graus F.
    Neuro-oncology 14:506-510(2012) [PubMed] [Europe PMC] [Abstract]
    Category: Sequences.
    Annotation: This study shows a very high frequency of HER2 overexpression in breast cancers in patients with anti-Yo-associated paraneoplastic cerebellar degeneration.Imported.
    Source: GeneRIF:1039.
  21. 21
    "Onconeuronal antigen Cdr2 correlates with HIF prolyl-4-hydroxylase PHD1 and worse prognosis in renal cell carcinoma."
    Kaufmann M.R., Schraml P., Hermanns T., Wenger R.H., Camenisch G.
    Exp. Mol. Pathol. 94:453-457(2013) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Expression.
    Annotation: Onconeuronal antigen Cdr2 correlates with HIF prolyl-4-hydroxylase PHD1 and worse prognosis in renal cell carcinoma.Imported.
    Source: GeneRIF:1039.
  22. 22
    Category: Interaction.
    Source: IntAct:Q01850.

    This publication is mapped to 4109 other entries.

  23. 23
    "Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration."
    Hwang J.Y., Lee J., Oh C.K., Kang H.W., Hwang I.Y., Um J.W., Park H.C., Kim S., Shin J.H., Park W.Y., Darnell R.B., Um H.D., Chung K.C., Kim K., Oh Y.J.
    Cell Death Dis 7:e2240-e2240(2016) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: the role of cdr2 in experimental models of Parkinson's disease is reported.Imported.
    Source: GeneRIF:1039.
  24. 24
    "Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies."
    Raspotnig M., Haugen M., Thorsteinsdottir M., Stefansson I., Salvesen H.B., Storstein A., Vedeler C.A.
    Cancer Immunol. Immunother. 66:1463-1471(2017) [PubMed] [Europe PMC] [Abstract]
    Category: Expression.
    Annotation: Both cerebellar degeneration related protein 2 (CDR2) and cerebellar degeneration-related antigen CDR2L (CDR2L) are more widely expressed than previously thought both in normal and cancerous tissues.Imported.
    Source: GeneRIF:1039.

    This publication is mapped to 2 other entries.

  25. 25
    "Tumor-specific killer cells in paraneoplastic cerebellar degeneration."
    Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., Darnell R.B.
    Nat. Med. 4:1321-1324(1998) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Identifies cdr2-specific T cells in patients with paraneoplastic cerebellar degeneration; cells are evident by standard CTL and by cross-presentation of apoptotic cdr2-expressing cells.Imported.
    Source: GeneRIF:1039.
1 to 25 of 25  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again